The Arab Pesticides & Veterinary Drugs Mfg. Co. (ASE:MBED)

Achilles Therapeutics Income Statement

Financials in millions JOD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	37.74	35.71	29.94	24.24	22.63	22.56
Revenue Growth (YoY)	21.02%	19.27%	23.51%	7.12%	0.29%	15.20%
Cost of Revenue	25.25	23.83	20.16	15.96	14.64	14.73
Gross Profit	12.49	11.88	9.78	8.28	7.98	7.83
Selling, General & Admin	3.93	3.83	3.38	2.77	2.8	2.64
Operating Expenses	4.38	4.27	3.61	3.17	3.2	3.04
Operating Income	8.11	7.61	6.17	5.11	4.79	4.79
Interest Expense	-0.33	-0.33	-0.29	-0.23	-0.28	-0.24
Earnings From Equity Investments	0.24	0.34	0.31	0.29	0.32	0.2
Other Non Operating Income (Expenses)	0.18	0.14	0.06	0.07	0.04	0.01
Pretax Income	8.21	7.77	6.25	5.24	4.86	4.77
Income Tax Expense	0.6	0.52	0.47	0.38	0.4	0.38
Earnings From Continuing Operations	7.6	7.24	5.78	4.86	4.45	4.39
Minority Interest in Earnings	-1.58	-1.54	-1.3	-0.95	-0.91	-1.06
Net Income	6.02	5.7	4.47	3.91	3.55	3.32
Net Income to Common	6.02	5.7	4.47	3.91	3.55	3.32
Net Income Growth	24.81%	27.44%	14.44%	10.17%	6.71%	36.76%
Shares Outstanding (Basic)	16	17	16	15	15	15
Shares Outstanding (Diluted)	16	17	16	15	15	15
Shares Change (YoY)	1.25%	6.45%	3.33%	-	-	-
EPS (Basic)	0.37	0.35	0.29	0.26	0.24	0.22
EPS (Diluted)	0.37	0.35	0.29	0.26	0.24	0.22
EPS Growth	23.27%	19.72%	10.75%	10.17%	6.71%	36.76%
Free Cash Flow	1.77	2.47	-0.99	0.29	3.06	1.12
Free Cash Flow Per Share	0.11	0.15	-0.06	0.02	0.20	0.07
Dividend Per Share	0.110	0.110	0.100	0.100	0.080	0.080
Dividend Growth	10.00%	10.00%	-	25.00%	-	-
Gross Margin	33.09%	33.27%	32.66%	34.17%	35.29%	34.72%
Operating Margin	21.49%	21.32%	20.61%	21.10%	21.15%	21.23%
Profit Margin	15.96%	15.96%	14.94%	16.12%	15.68%	14.73%
Free Cash Flow Margin	4.69%	6.91%	-3.31%	1.18%	13.53%	4.96%
EBITDA	8.67	8.15	6.67	5.58	5.19	5.33
EBITDA Margin	22.96%	22.82%	22.27%	23.03%	22.93%	23.61%
D&A For EBITDA	0.56	0.54	0.5	0.47	0.4	0.54
EBIT	8.11	7.61	6.17	5.11	4.79	4.79
EBIT Margin	21.49%	21.32%	20.61%	21.10%	21.15%	21.23%
Effective Tax Rate	7.34%	6.71%	7.59%	7.28%	8.31%	7.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.